CFDE Data Portal | Search RPL21P46

	Label	Description
	RPL21P46 associations Collection (Entity type)	Associations for RPL21P46_associations
	RPL21P46 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	RPL21P46 Gene (Entity type)	ENSG00000241612 - ribosomal protein L21 pseudogene 46
	GSE100148 EZH2 inhibition 4 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE206927 PPARG knockdown endothelial cell 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE200538 butyrolactone Hep-G2 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE183606 rutaecarpine 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Pancreas 20-29 vs 60-69 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Testis 20-29 vs 30-39 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Bladder 20-29 vs 50-59 Up Gene Set (Entity type)	A Gene Set from GTEx

RPL21P46 associations

Associations for RPL21P46_associations

RPL21P46 associations.tsv

A file from IDG as part of the Harmonizome project

RPL21P46

ENSG00000241612 - ribosomal protein L21 pseudogene 46

GSE100148 EZH2 inhibition 4 v 7 human dn

A Gene Set from LINCS

GSE206927 PPARG knockdown endothelial cell 1 v 3 human up

A Gene Set from LINCS

GSE200538 butyrolactone Hep-G2 1 v 2 human dn

A Gene Set from LINCS

GSE183606 rutaecarpine 1 v 0 human up

A Gene Set from LINCS

GTEx Pancreas 20-29 vs 60-69 Up

A Gene Set from GTEx

GTEx Testis 20-29 vs 30-39 Up

A Gene Set from GTEx

GTEx Bladder 20-29 vs 50-59 Up

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.